Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2000

View Archived Issues

Advanced Tissue Sciences restructures joint venture for Dermagraft during Q4

Lundbeck highlights significant events during 1999

Lilly files NDA for new formulation of Prozac for depression

IND filed by NeoPharm for glioblastoma treatment

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

CytRx to continue Flocor development as treatment for sickle cell disease

Aventis launches new antibiotic in Canada

Anesta renegotiates U.S. marketing rights for Actiq with Abbott

Multiple-dose clinical study of Betabloc as Alzheimer's therapy to begin soon

EGF receptor tyrosine kinase inhibitor selected for clinical testing at Parke-Davis

Otsuka prepares new orally active analgesic agents

Maleimide PKC inhibitors designed by Japan Tobacco

New agents for insulin resistance syndrome in the Merck pipeline

Meiji Seika discloses wide series of carbapenems and orally bioavailable esters

Neurocrine Biosciences' GnRH antagonist program advances

Rhein Biotech aims to become a world leader in vaccines with GCV acquisition

Selective glucocorticoid receptor modulators discovered by Abbott

Ampakine-like compounds for psychiatric and neurological disorders

Antiepileptic agents under study at Arzneimittelwerk Dresden

Potent, selective c-Src TK inhibitor identified using new target-based method

BOM-1006 selected as a lead benzimidazole for the development of antiallergic agents

Schering-Plough to copromote Tequin in U.S.; Tequin evaluated in PROVE IT trial

New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting

Continued treatment with Enbrel safe and effective in chronic heart failure

Nicostatin effective for increasing "good" cholesterol, lowering "bad" cholesterol

Monsanto and Pharmacia & Upjohn proceed towards completion of merger

Novel features of H-345/52 indicate promising activity in tachyarrhythmia

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...